Converting enzyme inhibitor and saralasin infusion in rats. Evidence for an additional vasodepressor property of converting enzyme inhibitor.
Authors:
- H ThurstonHTH Thurston
- J D SwalesJSJ D Swales
- 1 May 1978
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 42 (5) , 588-592
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Accentuated Vascular and Endocrine Response to Sq 20881 in HypertensionNew England Journal of Medicine, 1977
- Possible Role of Renin in Hypertension as Suggested by Renin-Sodium Profiling and Inhibition of Converting EnzymeNew England Journal of Medicine, 1977
- Estimating renin participation in hypertension: Superiority of converting enzyme inhibitor over saralasinThe American Journal of Medicine, 1976
- Response of the kallikrein-kinin and renin-angiotensin systems to saline infusion and upright posture.Journal of Clinical Investigation, 1975
- Inhibition of angiotensin conversion and prevention of renal hypertensionAmerican Journal of Physiology-Legacy Content, 1975
- Angiotensin-Sodium Interaction in Blood Pressure Maintenance of Renal Hypertensive and Normotensive RatsScience, 1973
- Inhibition of Angiotensin Conversion in Experimental Renovascular HypertensionScience, 1972
- Inhibition of Pressor Effects of Angiotensin I and Augmentation of Depressor Effects of Bradykinin by Synthetic PeptidesExperimental Biology and Medicine, 1972
- Hypertension of Renal Origin: Evidence for Two Different MechanismsScience, 1971